ASCI / Young Physician-Scientist Awards, 2021

The Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.

View all ASCI awards

Lenette Lu, MD, PhD
University of Texas Southwestern Medical Center
(Affiliation at the time of recognition)

About the awardee

Lenette Lu, MD, PhD, graduated with a BA in the Honors Program with a major in Biology and minor in Asian Studies from Swarthmore College where she worked in the laboratory of Elizabeth Vallen on yeast cell cycle regulation. As part of the Medical Scientist Training Program at Case Western Reserve University, she obtained an MD and PhD in Molecular Virology under Ganes Sen, working on dsRNA mediated signaling and innate immunity in the context of paramyxovirus infections. She completed an internship and residency in Internal Medicine at New York-Presbyterian – Weill Cornell and a fellowship in Infectious Diseases in the Partners program at Massachusetts General Hospital and Brigham and Women’s Hospital. Her postdoctoral research under Sarah Fortune at the Harvard T.H. Chan School of Public Health and Galit Alter at the Ragon Institute of MGH, MIT, and Harvard focused on understanding humoral immune responses to Mycobacterium tuberculosis. Dr. Lu’s initial work characterized divergent humoral profiles in patients with clinically characterized distinct tuberculosis (TB) disease states that support an immunomodulatory role for antibodies. Using this approach, she went on to examine a population of individuals highly exposed to Mtb yet clinically not recognized as part of the spectrum of human disease. She showed robust humoral profiles in the context of non-canonical T cell responses, providing immunological parameters to help define an additional state of human TB and an alternative model towards understanding host responses to Mtb exposure. Dr. Lu joined the Division of Infectious Diseases and Geographic Medicine at UT Southwestern in 2019 with a clinical practice at Parkland Hospital and research lab aimed at identifying the mechanisms by which antibodies modulate the host immune response in TB. Beyond TB, dissecting antibody functions is fundamentally relevant to all infectious disease where antibodies interface host and microbe, informing diagnostic, therapeutic and vaccine design.